Automated distal coronary bypass with a novel magnetic coupler (MVP system) F Filsoufi, MD, R.S Farivar, MD, L Aklog, MD, C.A Anderson, MD, R.H Chen, MD, S Lichtenstein, MD, J Zhang, MD, D.H Adams, MD The Journal of Thoracic and Cardiovascular Surgery Volume 127, Issue 1, Pages 185-192 (January 2004) DOI: 10.1016/j.jtcvs.2003.04.005
Figure 1 Enabling technologies that facilitate minimally invasive cardiac surgery. MIDCAB, Minimally invasive coronary artery bypass; OPCAB, off-pump coronary artery bypass; TECAB, total endoscopic coronary artery bypass. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 185-192DOI: (10.1016/j.jtcvs.2003.04.005)
Figure 2 MVP system: A, elliptical magnets; B, delivery device. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 185-192DOI: (10.1016/j.jtcvs.2003.04.005)
Figure 3 Illustration of the MVP system: 1, 2, and 3, Construction of anastomotic docking port; 4, creation of the anastomosis by approximation of the 2 magnetic ports. The device measures 3.0 mm at the minor axis and 7.0 mm at the major axis and is 0.4 mm thick. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 185-192DOI: (10.1016/j.jtcvs.2003.04.005)
Figure 4 Angiography at 1 month: LITA-to-LAD anastomosis with MVP system. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 185-192DOI: (10.1016/j.jtcvs.2003.04.005)
Figure 5 Histologic study. A, Internal gross appearance of the lumen of the implant at 6 months on both graft and coronary sides. B, Hematoxylin and eosin–stained section of tissue encapsulating outside and lumen of MVP implants. C, Factor VIII–stained section demonstrating a continuous single endothelial layer covering the MVP lumen. D, Hematoxylin and eosin–stained section (100×) showing viable tissue between MVP port implants. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 185-192DOI: (10.1016/j.jtcvs.2003.04.005)
Figure 5 Histologic study. A, Internal gross appearance of the lumen of the implant at 6 months on both graft and coronary sides. B, Hematoxylin and eosin–stained section of tissue encapsulating outside and lumen of MVP implants. C, Factor VIII–stained section demonstrating a continuous single endothelial layer covering the MVP lumen. D, Hematoxylin and eosin–stained section (100×) showing viable tissue between MVP port implants. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 185-192DOI: (10.1016/j.jtcvs.2003.04.005)
Figure 5 Histologic study. A, Internal gross appearance of the lumen of the implant at 6 months on both graft and coronary sides. B, Hematoxylin and eosin–stained section of tissue encapsulating outside and lumen of MVP implants. C, Factor VIII–stained section demonstrating a continuous single endothelial layer covering the MVP lumen. D, Hematoxylin and eosin–stained section (100×) showing viable tissue between MVP port implants. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 185-192DOI: (10.1016/j.jtcvs.2003.04.005)
Figure 5 Histologic study. A, Internal gross appearance of the lumen of the implant at 6 months on both graft and coronary sides. B, Hematoxylin and eosin–stained section of tissue encapsulating outside and lumen of MVP implants. C, Factor VIII–stained section demonstrating a continuous single endothelial layer covering the MVP lumen. D, Hematoxylin and eosin–stained section (100×) showing viable tissue between MVP port implants. The Journal of Thoracic and Cardiovascular Surgery 2004 127, 185-192DOI: (10.1016/j.jtcvs.2003.04.005)